Nu-Med Plus Inc logo

Nu-Med Plus Inc

NEW
OTCPK:NUMD (USA)  
$ 0.023 -0.0014 (-5.74%) 10:08 PM EST
N/A
Market Cap:
$ 1.92M
Enterprise V:
$ 2.14M
Volume:
0
Avg Vol (2M):
45.57K
Trade In:
Volume:
0
Avg Vol (2M):
45.57K

Business Description

Nu-Med Plus Inc logo
Nu-Med Plus Inc
NAICS : 339112 SIC : 3841
ISIN : US67021R1041

Total Employee Number:

2
Description
Nu-Med Plus Inc is a medical device company engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems, and the medical community throughout the world. It is currently working to locate a merger partner that will be able to fund the final development of these products.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt
0.02
Equity-to-Asset
-20.54
Debt-to-Equity
-0.84
Debt-to-EBITDA
-20.27
Piotroski F-Score
4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Book Growth Rate
-44.2

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
59.01
9-Day RSI
64.45
14-Day RSI
65.35
3-1 Month Momentum %
80.39
6-1 Month Momentum %
20.26
12-1 Month Momentum %
-41.03

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.05
Quick Ratio
0.05
Cash Ratio
0.02

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-0.9
Shareholder Yield %
-5.97

Profitability Rank

Name Current Vs Industry Vs History
ROA %
-256.1
ROIC %
-29.29
3-Year ROIIC %
118.75
Years of Profitability over Past 10-Year
2
Moat Score
3
Tariff Resilience Score
4

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio
N/A
N/A
N/A
PE Ratio without NRI
N/A
N/A
N/A
EV-to-EBIT
-194.45
EV-to-EBITDA
-194.45
EV-to-FCF
-41.94
Earnings Yield (Greenblatt) %
-0.51
FCF Yield %
-2.65

Financials

NUMD's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:NUMD

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Nu-Med Plus Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -
Beta -8.3348
3-Year Sharpe Ratio 0.54
3-Year Sortino Ratio 3.42
Volatility % 109.1
14-Day RSI 65.35
14-Day ATR ($) 0.000651
20-Day SMA ($) 0.020605
12-1 Month Momentum % -41.03
52-Week Range ($) 0.0095 - 0.045
Shares Outstanding (Mil) 83.55

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nu-Med Plus Inc Filings

Filing Date Document Date Form
No Filing Data

Nu-Med Plus Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Nu-Med Plus Inc Frequently Asked Questions

What is Nu-Med Plus Inc(NUMD)'s stock price today?
The current price of NUMD is $0.02. The 52 week high of NUMD is $0.05 and 52 week low is $0.01.
When is next earnings date of Nu-Med Plus Inc(NUMD)?
The next earnings date of Nu-Med Plus Inc(NUMD) is .
Does Nu-Med Plus Inc(NUMD) pay dividends? If so, how much?
Nu-Med Plus Inc(NUMD) does not pay dividend.

Guru Commentaries on OTCPK:NUMD

No fund manager commentary yet.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1